HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel C Nussenzweig Selected Research

Immunoglobulin Isotypes

6/201353BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel C Nussenzweig Research Topics

Disease

90Infections
04/2022 - 01/2002
30COVID-19
02/2022 - 01/2020
11Viremia
01/2021 - 10/2013
9Neoplasms (Cancer)
01/2017 - 01/2007
8Lymphoma (Lymphomas)
01/2017 - 01/2007
5Genetic Translocation (Chromosomal Translocation)
01/2017 - 10/2007
5Malaria
02/2016 - 12/2002
5Genomic Instability
06/2013 - 05/2002
5Ataxia Telangiectasia (Louis Bar Syndrome)
02/2013 - 11/2004
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2013 - 09/2007
4Reinfection
01/2022 - 01/2020
3HIV Infections (HIV Infection)
04/2022 - 12/2020
3Vesicular Stomatitis
12/2021 - 01/2021
3Severe Acute Respiratory Syndrome
06/2021 - 12/2020
3Pneumonia (Pneumonitis)
01/2021 - 10/2020
3Autoimmune Diseases (Autoimmune Disease)
10/2020 - 01/2004
3Inflammation (Inflammations)
04/2016 - 01/2002
3Acquired Immunodeficiency Syndrome (AIDS)
04/2015 - 06/2013
3Plasmacytoma
07/2012 - 08/2004
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2008 - 03/2005
2Breakthrough Infections
07/2022 - 10/2021
2Burkitt Lymphoma (Burkitt's Lymphoma)
07/2012 - 08/2004
2Nijmegen Breakage Syndrome
01/2007 - 12/2001
1Convalescence
10/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1Omsk Hemorrhagic Fever (Fever, Omsk Hemorrhagic)
01/2021
1Kyasanur Forest Disease
01/2021
1Louping Ill
01/2021
1Asymptomatic Infections
01/2021
1Chronic Hepatitis B
12/2020
1Emerging Communicable Diseases (Emerging Infectious Diseases)
10/2020
1Zika Virus Infection
01/2020
1Microcephaly
10/2019
1Leukemia
01/2017
1Lentivirus Infections
01/2017
1Persistent Infection
01/2017
1Hepatitis A (Hepatitis, Infectious)
05/2016
1Experimental Melanoma
06/2014
1Diphtheria
02/2014

Drug/Important Bio-Agent (IBA)

59AntibodiesIBA
04/2022 - 01/2004
34Broadly Neutralizing AntibodiesIBA
04/2022 - 12/2012
23VaccinesIBA
07/2022 - 10/2010
22Neutralizing AntibodiesIBA
07/2022 - 09/2012
13Monoclonal AntibodiesIBA
04/2021 - 09/2014
13DNA (Deoxyribonucleic Acid)IBA
01/2017 - 12/2001
10AntigensIBA
10/2021 - 01/2003
9EpitopesIBA
01/2022 - 04/2009
9Cytidine DeaminaseIBA
12/2014 - 11/2009
8Immunoglobulins (Immunoglobulin)IBA
01/2020 - 08/2004
6Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2001
5mRNA VaccinesIBA
02/2022 - 06/2021
5AutoantibodiesIBA
01/2022 - 03/2005
5Antiviral Agents (Antivirals)IBA
04/2021 - 06/2020
5Glycoproteins (Glycoprotein)IBA
06/2016 - 06/2004
5Histones (Histone)IBA
11/2008 - 12/2001
4Messenger RNA (mRNA)IBA
07/2022 - 01/2021
4chenodeoxycholate sulfate conjugate (CDCS)IBA
04/2016 - 06/2012
3Immunoglobulin G (IgG)IBA
01/2021 - 07/2008
3Antigen Receptors (Antigen Receptor)IBA
10/2007 - 01/2007
2BNT162 VaccineIBA
12/2021 - 10/2021
2remdesivirIBA
04/2021 - 01/2021
2Single-Domain AntibodiesIBA
03/2021 - 01/2021
2CytokinesIBA
01/2021 - 05/2007
2Explosive Agents (Explosives)IBA
11/2020 - 06/2020
2InterferonsIBA
10/2020 - 05/2007
2Polysaccharides (Glycans)IBA
01/2019 - 02/2017
2Pharmaceutical PreparationsIBA
11/2018 - 04/2015
2AutoantigensIBA
09/2010 - 01/2002
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
11/2009 - 12/2001
2Phosphotransferases (Kinase)IBA
11/2008 - 11/2004
2Mannose ReceptorIBA
11/2003 - 01/2003
12019-nCoV Vaccine mRNA-1273IBA
10/2021
1Immunoglobulin M (IgM)IBA
01/2021
1ogalvibartIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1crexavibartIBA
01/2021
1Prednisolone (Predate)FDA LinkGeneric
01/2021
1Recombinant ProteinsIBA
10/2020
1Biomarkers (Surrogate Marker)IBA
10/2020
1ProteomeIBA
10/2020
1Antigen-Antibody Complex (Immune Complex)IBA
01/2019
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
11/2018
1Bispecific AntibodiesIBA
01/2018
1HLA-B57 antigenIBA
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
04/2016
1Indicators and Reagents (Reagents)IBA
04/2015
1Poly I-CIBA
06/2014
1LigandsIBA
06/2014
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
02/2014
1Interleukin-23 (Interleukin 23)IBA
09/2013
1Interleukin-22 (IL-22)IBA
09/2013
1Alanine (L-Alanine)FDA Link
06/2013
1Immunoglobulin IsotypesIBA
06/2013
1flt3 ligand protein (flt3 ligand)IBA
06/2013

Therapy/Procedure

12Therapeutics
04/2022 - 08/2009
7Immunotherapy
01/2022 - 10/2013
5Art Therapy
04/2022 - 10/2013
1Aftercare (After-Treatment)
01/2021
1Injections
01/2019
1Highly Active Antiretroviral Therapy (HAART)
11/2018